Results 91 to 100 of about 20,522 (204)

Ezetimibe and vascular endothelial function. [PDF]

open access: yes, 2011
Hypercholesterolemia is a major risk factor for cardiovascular diseases that has been managed mostly with 3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors (statins) that suppress de novo cholesterol synthesis in the liver.
Maemura, Koji, Ikeda, Satoshi
core   +2 more sources

The ezetimibe controversy: implications for clinical practice

open access: yes, 2011
Low-density lipoprotein cholesterol (LDL-C) remains the primary target of lipid-lowering therapy. Achieving LDL-C goals as outlined by the National Cholesterol Education Program Adult Treatment Panel III can be difficult with statins alone; therefore ...
Ujjaini Khanderia   +3 more
core   +1 more source

Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytes

open access: yesJournal of Lipid Research, 2012
Enterocyte cholesterol homeostasis reflects aggregated rates of sterol synthesis, efflux, and uptake from plasma and gut lumen. Cholesterol synthesis and LDL uptake are coordinately regulated by sterol regulatory element-binding proteins (SREBP), whereas
Luke J. Engelking   +3 more
doaj   +1 more source

Ezetimibe (Ezetrol)

open access: yes, 2004
peer reviewedEzetimibe (Ezetrol), recently launched in Belgium by Merck Sharp& Dohme and Schering Plough, is presented as 10 mg tablets. It belongs to a new class of lipid-lowering agents that selectively inhibit the intestinal absorption of cholesterol ...
Scheen, André
core  

Combination of Ezetimibe and Garlic Reduces Serum Lipids and Intestinal Niemann-Pick C1-like 1 Expression More Effectively in Hypercholesterolemic Mice

open access: yesAvicenna Journal of Medical Biochemistry, 2015
Background Combination therapy plays an important role in the management of cardiovascular disease (CVD). Objectives The aim of this experiment was to study the influence of garlic combined with ezetimibe ...
Mohammadi   +5 more
doaj   +1 more source

The lipid-lowering effect of ezetimibe in pure vegetarians

open access: yesJournal of Lipid Research, 2006
Results of previous studies have shown that ezetimibe (10 mg/day) reduces LDL cholesterol in patients with mild hypercholesterolemia on a normal-cholesterol diet (dietary intake of 200–500 mg/day) by 16–22%.
Jacob J. Clarenbach   +4 more
doaj   +1 more source

Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats

open access: yes, 2020
AIM: To investigate whether ezetimibe ameliorates hepatic steatosis and induces autophagy in a rat model of obesity and type 2 diabetes. METHODS: Male age-matched lean control LETO and obese and diabetic OLETF rats were administered either PBS or ...
장유진
core   +1 more source

Pengaruh Perbedaan Ukuran Partikel Dan Metode Pembuatan Tablet Terhadap Disolusi Ezetimibe [PDF]

open access: yes, 2022
Ezetimibe merupakan obat yang sukar larut dengan profil disolusi yang rendah. Untuk meningkatkan kelarutan suatu obat, dapat dilakukan dengan memperkecil ukuran partikel yang juga akan meningkatkan laju disolusi.
AYUNDA PITRA DWI INTANSARI
core  

Implications for ezetimibe therapy use based on IMPROVE-IT criteria

open access: yes, 2015
Purpose: In the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT), simvastatin/ezetimibe combination was associated with a 6% relative risk reduction in the combined cardiovascular outcome compared with simvastatin alone ...
Petersen, Laura A   +8 more
core  

Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events

open access: yesAnnals of Medicine
The EWTOPIA 75 (Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older) study supports the reduction in the risk of atherosclerotic cardiovascular disease (ASCVD) events with ezetimibe without statin therapy
Alpo Vuorio   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy